Results of epidemiological studies on the prevalence of iodine deficiency disorders in the Republic of Uzbekistan

Main Article Content

S.I. Ismailov
M.M. Rashitov


Background. In spite of the works performed against iodine deficiency disorders (IDD), they still remain severe in Uzbekistan. The purpose of the study was to investigate the dynamics of the prevalence of IDD among the population in the Republic of Uzbekistan. Materials and methods. Epidemiological study of IDD in the Republic of Uzbekistan has been performed according to the World Health Organization (WHO) recommendations. Degree of thyroid enlargement was determined according to the WHO classification. Such indexes, as assessment of urinary iodine concentration and evaluation of salt iodine concentration, have been analyzed. The data were compared with the results of previous years’ studies. Results. Estimation of the severity of IDD by the level of ioduria showed that the proportion of severe iodine deficiency (less than 20 μg/l) decreased from 94.4 % in 1998 to 21.4 % in 2004, to 1.9 % in 2010 and to 1.9 % in 2016. The optimal level of iodine intake (more than 100 μg/l) increased from 0 % in 1998 to 46.3 % in 2004, to 63.7 % in 2010 and 76.3 % in 2016. Comparative analysis of the prevalence of degree I and II diffuse goiter showed that in total the proportion of this disease was 72.8 % in 1998, 58.8 % in 2004, 40.2 % in 2010 and 28.3 % in 2016. Conclusions. The acceptance of law of Uzbekistan “On prevention of iodine deficiency diseases” in 2007 has substantially decreased the prevalence of IDD in Uzbekistan. Nevertheless, despite of large scale actions, our study of ioduria and salt iodine content in 2016 indicated that about 25 % of people in the country still prone to IDD.

Article Details

How to Cite
Ismailov, S., and M. Rashitov. “Results of Epidemiological Studies on the Prevalence of Iodine Deficiency Disorders in the Republic of Uzbekistan”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 3, June 2017, pp. 197-01, doi:10.22141/2224-0721.13.3.2017.104119.
Preventive Endocrinology


Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination. A guide for programme managers, Second Edition, WHO, 2002. Available from:

Ismailov SI, Rashitov MM, Atadjanova MM. et al. Universal salt iodization program in Uzbekistan: A cost-benefit analysis. European Applied Sciences. 2016;2:21-4.

Mokhort TV, Kolomiets ND, Petrenko SV, Fedorenko EV, Mokhort EG. Iodine Deficiency: Where Are We Now? (Efficiency of Belarusian Strategy in Elimination of Iodine Deficiency: 15-year Experience). Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2015;2:13-9. (In Russian). doi: 10.22141/2224-0721.2.66.2015.75430.

Universal salt iodization in Central and Eastern Europe and the CIS. The experience, achievements and lessons acquired during 2000–2009. Geneva: UNICEF, 2011.

Zimmermann M, Burgi H, Hurrell R. Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab. 2007;92(9):3436-40. doi: 10.1210/jc.2007-1082.

Raileanu I, Diosady L. Vitamin A stability in salt triple fortified with iodine, iron, and vitamin A. Food Nutr Bull. 2006;27(3):252-259. PMID: 17542116. doi: 10.1177/156482650602700308.

Witzke O. Differential T4 degradation pathways in young patients with preterminal and terminal renal failure. Horm Metab Res. 2007 May;39(5):355-8. PMID: 17533577. doi: 10.1055/s-2007-976536.

Zhao J, van der Haar F. Progress in salt iodization and improved iodine nutrition in China, 1995–99. Food Nutr Bull. 2004;25(4):337-43. doi: 10.1177/156482650402500403.

Pretell E, Delange F, Hostalek U. et al. Iodine nutrition improves in Latin America. Thyroid. 2004;14(8):590-9. doi: 10.1089/1050725041692909.

Ismailov SI, Nugmanova LB, Rashitov M.M, et al. Situational market of salt analysis from data of enterprises, productive iodine-treated salt in Uzbekistan. Zhurnal teoreticheskoj i klinicheskoj mediciny. 2012;6:16-24. (In Russian).

Most read articles by the same author(s)

1 2 3 > >>